Partner with Hikma.
We offer high-quality manufacturing capabilities, combining reliability and flexibility in our state-of-the-art facilities. With 30 manufacturing plants strategically located across the US, Europe, and the MENA region, we ensure that your needs are met with excellence.
Newsroom
All news stories Latest news
- Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg Press Release, Product 14 January 2025 Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg
- Hikma launches Meropenem for Injection, USP in the US Press Release, Product 14 January 2025 Hikma launches Meropenem for Injection, USP in the US
- Hikma to present at 43rd Annual J.P. Morgan Healthcare Conference Press Release, Corporate 13 January 2025 Hikma to present at 43rd Annual J.P. Morgan Healthcare Conference
- Hikma launches ePHEDrine Sulfate Injection, USP in the US Press Release, Product 30 December 2024 Hikma launches ePHEDrine Sulfate Injection, USP in the US
Related content